Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

May 01, 1992; Volume 41,Issue 5
  • You have access
    Neuropeptide Y1 subtype pharmacology of a recombinantly expressed neuropeptide receptor.
    J Krause, C Eva, P H Seeburg and R Sprengel
    Molecular Pharmacology May 1992, 41 (5) 817-821;
  • You have access
    Identification of three separate guanine nucleotide-binding proteins that interact with the delta-opioid receptor in NG108-15 neuroblastoma x glioma hybrid cells.
    S C Roerig, H H Loh and P Y Law
    Molecular Pharmacology May 1992, 41 (5) 822-831;
  • You have access
    Multiple states of rat brain (RS)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors as revealed by quantitative autoradiography.
    J H Cha, R L Makowiec, J B Penney and A B Young
    Molecular Pharmacology May 1992, 41 (5) 832-838;
  • You have access
    Chronic selegiline administration transiently decreases tyrosine hydroxylase activity and mRNA in the rat nigrostriatal pathway.
    S L Vrana, A J Azzaro and K E Vrana
    Molecular Pharmacology May 1992, 41 (5) 839-844;
  • You have access
    DNA-binding properties of a distamycin-ellipticine hybrid molecule.
    C Bailly, C O'Huigin, R Houssin, P Colson, C Houssier, C Rivalle, E Bisagni, J P Henichart and M J Waring
    Molecular Pharmacology May 1992, 41 (5) 845-855;
  • You have access
    Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens.
    T Shimada, C H Yun, H Yamazaki, J C Gautier, P H Beaune and F P Guengerich
    Molecular Pharmacology May 1992, 41 (5) 856-864;
  • You have access
    Human liver dehydroepiandrosterone sulfotransferase: molecular cloning and expression of cDNA.
    D M Otterness, E D Wieben, T C Wood, W G Watson, B J Madden, D J McCormick and R M Weinshilboum
    Molecular Pharmacology May 1992, 41 (5) 865-872;
  • You have access
    Characterization of a 5-lipoxygenase-activating protein binding assay: correlation of affinity for 5-lipoxygenase-activating protein with leukotriene synthesis inhibition.
    S Charleson, P Prasit, S Léger, J W Gillard, P J Vickers, J A Mancini, P Charleson, J Guay, A W Ford-Hutchinson and J F Evans
    Molecular Pharmacology May 1992, 41 (5) 873-879;
  • You have access
    Differences in effects of forskolin and an analog on calcium currents in cardiac myocytes suggest intra- and extracellular sites of action.
    H C Hartzell and D Budnitz
    Molecular Pharmacology May 1992, 41 (5) 880-888;
  • You have access
    Beta 1- and beta 2-adrenergic receptors display subtype-selective coupling to Gs.
    S A Green, B D Holt and S B Liggett
    Molecular Pharmacology May 1992, 41 (5) 889-893;
  • You have access
    Stimulation of adenylate cyclase by amylin in CHO-K1 cells.
    C S D'Santos, A Gatti, D R Poyner and M R Hanley
    Molecular Pharmacology May 1992, 41 (5) 894-899;
  • You have access
    Effects of low doses of bicuculline on N-methyl-D-aspartate single-channel kinetics are not evident in whole-cell currents.
    J M Wright and L M Nowak
    Molecular Pharmacology May 1992, 41 (5) 900-907;
  • You have access
    Forskolin acts as a noncompetitive inhibitor of nicotinic acetylcholine receptors.
    M L Aylwin and M M White
    Molecular Pharmacology May 1992, 41 (5) 908-913;
  • You have access
    Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain.
    A C Foster, J A Kemp, P D Leeson, S Grimwood, A E Donald, G R Marshall, T Priestley, J D Smith and R W Carling
    Molecular Pharmacology May 1992, 41 (5) 914-922;
  • You have access
    Characterization of the binding of [3H]L-689,560, an antagonist for the glycine site on the N-methyl-D-aspartate receptor, to rat brain membranes.
    S Grimwood, A M Moseley, R W Carling, P D Leeson and A C Foster
    Molecular Pharmacology May 1992, 41 (5) 923-930;
  • You have access
    Nicotinic acetylcholine currents in cultured postnatal rat hippocampal neurons.
    C F Zorumski, L L Thio, K E Isenberg and D B Clifford
    Molecular Pharmacology May 1992, 41 (5) 931-936;
  • You have access
    Ambenonium is a rapidly reversible noncovalent inhibitor of acetylcholinesterase, with one of the highest known affinities.
    A S Hodge, D R Humphrey and T L Rosenberry
    Molecular Pharmacology May 1992, 41 (5) 937-942;
  • You have access
    Free radical metabolism of halothane in vivo: radical adducts detected in bile.
    K T Knecht, J A DeGray and R P Mason
    Molecular Pharmacology May 1992, 41 (5) 943-949;
  • You have access
    Membrane permeation characteristics of 5'-modified thymidine analogs.
    B A Domin, W B Mahony, G W Koszalka, D J Porter, G Hajian and T P Zimmerman
    Molecular Pharmacology May 1992, 41 (5) 950-956;
  • You have access
    Role of desolvation energy in the nonfacilitated membrane permeability of dideoxyribose analogs of thymidine.
    L L Wright and G R Painter
    Molecular Pharmacology May 1992, 41 (5) 957-962;
  • You have access
    Common features in the interaction of tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one and -thione and 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives with the human immunodeficiency virus type 1 reverse transcriptase.
    Z Debyser, R Pauwels, M Baba, J Desmyter and E De Clercq
    Molecular Pharmacology May 1992, 41 (5) 963-968;
  • You have access
    Effects of L-histidine on hydrogen peroxide-induced DNA damage and cytotoxicity in cultured mammalian cells.
    O Cantoni, P Sestili, A Guidarelli, P U Giacomoni and F Cattabeni
    Molecular Pharmacology May 1992, 41 (5) 969-974;
  • You have access
    Human liver microsomal N-hydroxylation of dapsone by cytochrome P-4503A4.
    C M Fleming, R A Branch, G R Wilkinson and F P Guengerich
    Molecular Pharmacology May 1992, 41 (5) 975-980;
  • You have access
    Imprinting of hepatic microsomal cytochrome P-450 enzyme activities and cytochrome P-450IIC11 by peripubertal administration of testosterone in female rats.
    B J Cadario, G D Bellward, S Bandiera, T K Chang, W W Ko, E Lemieux and R C Pak
    Molecular Pharmacology May 1992, 41 (5) 981-988;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 41, Issue 5
1 May 1992
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Histamine H3 Receptor
  • Cardiac Safety of Doxorubicin
  • Wnt Signaling and Drug Resistance in Cancer
  • Salicylate Blocks Lipolytic Actions of Tumor Necrosis Factor-α in Primary Rat Adipocytes
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics